NYSE:WAT - Waters Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Waters Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $228.97 +1.04 (+0.46 %) (As of 12/11/2019 04:00 PM ET) Add Compare Today's Range$226.24Now: $228.97▼$229.1950-Day Range$209.49MA: $218.30▼$227.4552-Week Range$173.41Now: $228.97▼$255.21Volume340,591 shsAverage Volume575,615 shsMarket Capitalization$14.75 billionP/E Ratio27.62Dividend YieldN/ABeta1.04 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry Analytical instruments Sub-IndustryLife Sciences Tools & Services SectorComputer and Technology Current SymbolNYSE:WAT Previous Symbol CUSIP94184810 CIK1000697 Webhttp://www.waters.com/ Phone508-478-2000Debt Debt-to-Equity Ratio11.40 Current Ratio2.25 Quick Ratio1.63Price-To-Earnings Trailing P/E Ratio27.62 Forward P/E Ratio25.93 P/E Growth2.69 Sales & Book Value Annual Sales$2.42 billion Price / Sales6.10 Cash Flow$10.05 per share Price / Cash Flow22.79 Book Value$20.69 per share Price / Book11.07Profitability EPS (Most Recent Fiscal Year)$8.29 Net Income$593.79 million Net Margins23.98% Return on Equity77.73% Return on Assets20.16%Miscellaneous Employees7,200 Outstanding Shares64,434,000Market Cap$14.75 billion Next Earnings Date1/22/2020 (Estimated) OptionableOptionable Receive WAT News and Ratings via Email Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter. WAT Rates by TradingView Waters (NYSE:WAT) Frequently Asked Questions What is Waters' stock symbol? Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT." How will Waters' stock buyback program work? Waters announced that its Board of Directors has approved a share repurchase plan on Tuesday, April 24th 2018, which authorizes the company to buyback $3,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 18.2% of its stock through open market purchases. Stock buyback plans are often a sign that the company's board believes its shares are undervalued. How were Waters' earnings last quarter? Waters Co. (NYSE:WAT) issued its quarterly earnings results on Tuesday, October, 29th. The medical instruments supplier reported $2.13 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $2.13. The medical instruments supplier earned $577.28 million during the quarter, compared to the consensus estimate of $588.35 million. Waters had a net margin of 23.98% and a return on equity of 77.73%. The business's revenue was down .1% on a year-over-year basis. During the same period in the prior year, the company earned $1.92 earnings per share. View Waters' Earnings History. When is Waters' next earnings date? Waters is scheduled to release their next quarterly earnings announcement on Wednesday, January 22nd 2020. View Earnings Estimates for Waters. What guidance has Waters issued on next quarter's earnings? Waters updated its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided EPS guidance of $2.95-3.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.23. The company issued revenue guidance of $715-729 million, compared to the consensus revenue estimate of $735.22 million. What price target have analysts set for WAT? 10 brokerages have issued 1 year target prices for Waters' stock. Their forecasts range from $177.00 to $260.00. On average, they expect Waters' share price to reach $208.71 in the next twelve months. This suggests that the stock has a possible downside of 8.8%. View Analyst Price Targets for Waters. What is the consensus analysts' recommendation for Waters? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 5 sell ratings and 5 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Waters. Has Waters been receiving favorable news coverage? News stories about WAT stock have trended somewhat negative on Wednesday, according to InfoTrie. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Waters earned a coverage optimism score of -1.7 on InfoTrie's scale. They also assigned news stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Waters. Who are some of Waters' key competitors? Some companies that are related to Waters include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Bruker (BRKR), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE). What other stocks do shareholders of Waters own? Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Home Depot (HD), Alibaba Group (BABA), Honeywell International (HON), CVS Health (CVS), Raytheon (RTN), Verizon Communications (VZ), Cisco Systems (CSCO), QUALCOMM (QCOM) and Johnson & Johnson (JNJ). Who are Waters' key executives? Waters' management team includes the folowing people: Christopher James O'Connell, Chairman & CEO (Age 52)Mr. Christopher James O'Connell, Chairman & CEO (Age 52)Ms. Sherry L. Buck, Sr. VP & CFO (Age 55)Mr. Francis S. Kim, Sr. VP of Global Operations (Age 52)Mr. Robert G. Carson, Sr. VP of Corp. Devel. & Interim Pres of TA Bus. (Age 45) Who are Waters' major shareholders? Waters' stock is owned by many different of institutional and retail investors. Top institutional investors include Massachusetts Financial Services Co. MA (8.65%), State Street Corp (4.67%), Marathon Asset Management LLP (0.69%), Man Group plc (0.69%), Select Equity Group L.P. (0.67%) and Beck Mack & Oliver LLC (0.58%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Edward Conard, Elizabeth B Rae, Eugene G Cassis, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Institutional Ownership Trends for Waters. Which institutional investors are selling Waters stock? WAT stock was sold by a variety of institutional investors in the last quarter, including State of Tennessee Treasury Department, State Street Corp, First Trust Advisors LP, Robecosam AG, Fenimore Asset Management Inc., Pictet Asset Management Ltd., Marathon Asset Management LLP and Harvey Investment Co. LLC. Company insiders that have sold Waters company stock in the last year include Edward Conard, Elizabeth B Rae, Ian King, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters. Which institutional investors are buying Waters stock? WAT stock was bought by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Select Equity Group L.P., Anchor Capital Advisors LLC, State of New Jersey Common Pension Fund D, Man Group plc, Assenagon Asset Management S.A., California Public Employees Retirement System and Ferguson Wellman Capital Management Inc.. View Insider Buying and Selling for Waters. How do I buy shares of Waters? Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Waters' stock price today? One share of WAT stock can currently be purchased for approximately $228.84. How big of a company is Waters? Waters has a market capitalization of $14.75 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters. What is Waters' official website? The official website for Waters is http://www.waters.com/. How can I contact Waters? Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected] MarketBeat Community Rating for Waters (NYSE WAT)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 392 (Vote Outperform)Underperform Votes: 533 (Vote Underperform)Total Votes: 925MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/11/2019 by MarketBeat.com StaffFeatured Article: Leveraged Buyout (LBO) Explained